What changed
$MCK — WATCHLIST 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $96.3B | EPS $11.69 vs $11.57 🟢
💡 Consensus expected EPS $11.57 vs $11.69 actual, a 1% beat. The small upside surprise suggests no material gap; the market likely viewed this as in-line, offering no catalyst for repricing.
📉 Reward/risk: 1.22:1
🏢 Business Quality: 8 — wide moat from scale in distribution, essential healthcare services, low margin but resilient cash flows./10
📊 Valuation: fair — based on approximated TTM P/E ~19x, relative to peers trading at 16-18x, using trailing EPS. No clear discount or premium.
🔮 Catalyst: Recent earnings report (March 2026) already passed; no incremental catalyst identified in the next 3 months
💰 Entry: $766.55, stop $735, target $805
📊 Our read: WATCHLIST. Full analysis →
https://stockduty.xyz/s/MCK0625